Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
SZSE:300534.SZ
9.22 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 83.852 | 30.296 | -6.298 | 3.283 | 15.364 | 12.278 | 17.112 | 47.252 | 60.677 | 60.424 | 40.912 | 0 | 0 |
| Depreciation & Amortization
| 29.901 | 20.021 | 22.565 | 19.504 | 19.838 | 17.81 | 15.868 | 6.082 | 3.355 | 3.105 | 2.726 | 0 | 0 |
| Deferred Income Tax
| -1.294 | -1.482 | 0.241 | -3.163 | 0.186 | -0.264 | -1.445 | -0.397 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -30.451 | -43.649 | 30.253 | 17.972 | -10.013 | -20.279 | -36.643 | -43.873 | -37.56 | -23.899 | -5.524 | 0 | 0 |
| Accounts Receivables
| 2.59 | -97.196 | 34.527 | -3.181 | -0.463 | -1.33 | -38.866 | -61.749 | -52.303 | 0 | 0 | 0 | 0 |
| Inventory
| -11.646 | -7.692 | -12.793 | -2.037 | -6.087 | -8.844 | -8.177 | 25.885 | 11.285 | 0.863 | 14.502 | 0 | 0 |
| Accounts Payables
| -20.101 | 62.721 | 8.277 | 26.354 | -3.649 | -9.842 | 11.847 | -7.611 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | -1.482 | 0.241 | -3.163 | 0.186 | -11.436 | -28.465 | -69.757 | -48.845 | -24.762 | -20.026 | 0 | 0 |
| Other Non Cash Items
| 3.994 | 4.76 | 4.615 | 2.742 | 3.02 | 0.424 | 1.609 | 3.674 | 4.129 | -0.622 | -2.197 | 0 | 0 |
| Operating Cash Flow
| 96.526 | 11.427 | 51.135 | 43.501 | 28.209 | 10.233 | -2.054 | 13.135 | 30.602 | 39.008 | 35.917 | 0 | 0 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -126.359 | -13.626 | -0.414 | -18.552 | -28.523 | -2.776 | -55.72 | -53.031 | -164.658 | -99.355 | -60.941 | -24.154 | -12.208 |
| Acquisitions Net
| 1.68 | 15 | 0.013 | 0.001 | -22.021 | 0 | 0.112 | 0 | 164.658 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -15 | -20 | -20 | 0.166 | -88 | -55 | -52.2 | -2 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0.912 | 0.798 | 0.6 | 0.258 | 1.018 | 0.831 | 0 | 0.275 | 0.803 | 2.937 | 1.095 | 0 |
| Other Investing Activites
| 0 | 0 | 20 | 20 | -0.003 | 0 | 0.112 | -53.031 | -2 | 22 | -60.941 | -0 | -12.208 |
| Investing Cash Flow
| -126.359 | -12.714 | 0.398 | -17.952 | -50.124 | -1.758 | -54.777 | -105.231 | -166.382 | -76.552 | -58.004 | -23.059 | -12.208 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -139.5 | -20 | -70.066 | -24 | -24.646 | 0 | 0 | -170 | -150 | 0 | -50 | -16.5 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -3.817 | -0.495 | -0.535 | -3.033 | -3.033 | -4.032 | -8.667 | -7.317 | -25.704 | -19.494 | -12.419 | -7.281 | -0.808 |
| Other Financing Activities
| -186.402 | 1.32 | -0.535 | 70 | 39.291 | -0.392 | -0.219 | 251.672 | 269.7 | 7.84 | 196.56 | 122.557 | 10.43 |
| Financing Cash Flow
| -50.719 | -19.175 | -70.601 | 41.011 | 10.521 | -4.032 | -8.886 | 74.356 | 93.996 | -11.654 | 134.141 | 98.776 | 9.622 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | -0 | -0.006 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -80.552 | -1.287 | -19.068 | 66.554 | -11.395 | 4.443 | -65.716 | -17.74 | -41.785 | -49.198 | 112.054 | 111.341 | 7.578 |
| Cash At End Of Period
| 288.692 | 97.834 | 99.121 | 118.189 | 51.634 | 63.029 | 58.586 | 124.303 | 142.042 | 183.827 | 233.025 | 120.972 | 9.631 |